pyy 3-36
Peptideexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2006 (NCT00468884)
Timeline
Indications
Mechanism of action
- Neuropeptide Y receptor type 2ACTIVATOR
NPY2R activator
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- ac162352
- pyy 3-36
- pyy 3-36
- pyy 3-36
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02493959 | Early Phase 1 (Phase 1) | May 1, 2014 | University of Copenhagen |
| NCT00940134 | N/A | Mar 1, 2011 | University of Copenhagen |
| NCT00537420 | Phase 2 | Oct 1, 2007 | mdRNA |
| NCT00468884 | Phase 1 | Oct 1, 2006 | University of Basel, University of Bern |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Copenhagen | Academic/Hospital | 2 | 2 | 2 | 2011 |
| mdRNA | For profit | 1 | 1 | 1 | 2007 |
| University of Basel | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of Bern | Academic/Hospital | 1 | 1 | 1 | 2006 |
4 organizations
Page 1 / 1